• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Cumulative percentage of eligible contract dollars awarded to small businesses in the month

Dictionary: According to the Small Business Goaling Act of 2012, each Federal Agency must award to small businesses not less than 25 percent of the total value of all prime contract awards and 40% of the total value of all subcontract awards for each fiscal year. At a minimum, the contracts awarded to small businesses must include: 3% to veteran-owned businesses, 3% to HUBZone businesses, 5% to women-owned businesses, and 5% to disadvantaged businesses.

Information is current as of January 21, 2015.

Fiscal Year - 2015

Skip graphic and jump to text data

TimeTargetValue
Oct 20134094
Nov 20134091
Dec 201340TBD
Jan 201440TBD
Feb 201440TBD
Mar 201440TBD
Apr 201440TBD
May 201440TBD
Jun 201440TBD
Jul 201440TBD
Aug 201440TBD
Sep 201440TBD

FY 2015 YTD: 91%

Cumulative number of contract dollars awarded to small businesses in the month

Fiscal Year - 2015
Skip graphic and jump to text data.

TimeTargetValue
Oct 2014N/A16,249,881
Nov 2014N/A20,885,693
Dec 2014N/ATBD
Jan 2015N/ATBD
Feb 2015N/ATBD
Mar 2015N/ATBD
Apr 2015N/ATBD
May 2015N/ATBD
Jun 2015N/ATBD
Jul 2015N/ATBD
Aug 2015N/ATBD
Sep 2015N/ATBD

FY 2015 YTD: 20,885,693

Cumulative total number of eligible contract dollars awarded in the month

Fiscal Year - 2015
Skip graphic and jump to text data.

TimeTargetValue
Oct 2014N/A17,238,227
Nov 2014N/A22,919,248
Dec 2014N/ATBD
Jan 2015N/ATBD
Feb 2015N/ATBD
Mar 2015N/ATBD
Apr 2015N/ATBD
May 2015N/ATBD
Jun 2015N/ATBD
Jul 2015N/ATBD
Aug 2015N/ATBD
Sep 2015N/ATBD

FY 2015 YTD: 22,919,248

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.